Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-03-06

Clinical Trial Update: Effects of Aripiprazole (LAI) on Phychosocial/Cognitive Functioning, pt Reported AcceptabilityofTreatment in Sch [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the effects of long-acting injectable aripiprazole on psychosocial/cognitive functioning and patient-reported acceptability in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • aripiprazole LAI (aripiprazole)

Snippet

Sponsor: Abdi İbrahim Otsuka | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED